COVID-19 News

The Latest Scientific and Medical Developments on COVID-19

Click the social share buttons below to keep your friends and family up to date on the latest breakthroughs to fight COVID-19

Sign Up

Sign up for our regular newsletter to receive the latest trends and news from the California Biotechnology Industry

Name*
First
Email*
Email
This field is for validation purposes and should be left unchanged.

The Latest on COVID-19

The California Biotechnology Foundation is committed to keeping you up to date on COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of May 22, 2020. Notable advancements include:

Gilead Sciences has increased the number of remdesivir doses it is donating to the U.S. federal government from 607,000 to around 940,000.
AstraZeneca has concluded the first agreements for at least 400 million doses of the University of Oxford’s COVID-19 vaccine and has secured manufacturing capacity for one billion doses beginning first deliveries in September 2020.
Pfizer is expanding their research and manufacturing capacity to fulfill 20 million COVID-19 vaccine doses by the end of the year and advance clinical trials for antiviral treatments.

For more on Vaccines, Testing and Treatment, see our fact sheet HERE.